scholarly journals Langerhans Cell Histiocytosis Causing Central Nervous System Vasculitis Leading to Stroke in a Two-year-old Boy: A Case Report

Cureus ◽  
2019 ◽  
Author(s):  
Nathan T Froelich ◽  
Elias Rizk
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Langerhans Cell Histiocytosis ◽  
Langerhans Cell ◽  
Central Nervous System Vasculitis

Unusual Location of Central Nervous System Langerhans Cell Histiocytosis: Case Report

2003 ◽  
Vol 48 (3) ◽  
pp. 213
Author(s):  
E Yup Kim ◽  
Jae Kyu Lee ◽  
Chan Kyo Kim ◽  
Chang Hyun Lee ◽  
Chang Ho Kang ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Langerhans Cell Histiocytosis ◽  
Langerhans Cell ◽  
Unusual Location

Langerhans Cell Histiocytosis Involving Central Nervous System: A Case Report

1997 ◽  
Vol 36 (1) ◽  
pp. 29
Author(s):  
Won Jin Moon ◽  
Dong Woo Park ◽  
Seung Ro Lee ◽  
Chang Kok Hahm ◽  
Sung Tae Kim ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Langerhans Cell Histiocytosis ◽  
Langerhans Cell ◽  
System A

scholarly journals Solitary tibial lesion as the initial presentation of Langerhans cell histiocytosis: report of two cases and literature review

2021 ◽  
Vol 49 (1) ◽  
pp. 030006052098282
Author(s):  
Chih-Yang Lin ◽  
Chia-Che Lee ◽  
Kuan-Wen Wu ◽  
Chang-Tsu Yuan ◽  
Ken-Nan Kuo ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Langerhans Cell Histiocytosis ◽  
Paediatric Oncology ◽  
Bone Diseases ◽  
Langerhans Cell ◽  
Oncology Group ◽  
Preventive Chemotherapy ◽  
System Risk ◽  
Risk Patients

The various presentations of osseous Langerhans cell histiocytosis (LCH) make it difficult to distinguish from other bone diseases. In addition, there is no universally accepted protocol for managing osseous LCH for single non-central nervous system-risk lesions. Here, the rare cases of two paediatric patients, aged 1 and 2 years, who presented with a solitary tibial lesion at time of LCH diagnosis, are reported. One patient progressed to multiple lesions after curettage of the original lesion. Subsequently, both patients received preventive chemotherapy using the Taiwan Paediatric Oncology Group (TPOG) revised protocol for treating low risk patients with LCH, namely, TPOG LCH2002-LR. After receiving this treatment, which included a schedule of prednisolone and vincristine for 6 weeks, followed by prednisolone, vincristine and 6-mercaptopurine for a further 48 weeks, both patients are free from recurrence or progression.

scholarly journals Acute central nervous system vasculitis as a manifestation of neurosarcoidosis: A case report and literature review

2021 ◽  
Vol 16 (2) ◽  
pp. 410-414
Author(s):  
Toyonobu Maekawa ◽  
Yukihiro Goto ◽  
Takuma Aoki ◽  
Akihiko Hino ◽  
Hideki Oka ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Case Report ◽  
Literature Review ◽  
Central Nervous System Vasculitis

scholarly journals Adult Langerhans cell histiocytosis of the central nervous system

2020 ◽  
Vol 33 (4) ◽  
pp. 603-605
Author(s):  
Walter R. Duarte-Celada ◽  
Smathorn Thakolwiboon ◽  
Luis Brandi ◽  
Christopher Duarte-Celada ◽  
Mirla Avila
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Langerhans Cell Histiocytosis ◽  
Langerhans Cell ◽  
The Central Nervous System
Sign in / Sign up

Export Citation Format

Share Document